Shire notes the announcement made by Takeda. The Board of Shire (the "Board") confirms that it has received three conditional proposals from Takeda regarding a possible offer for the Company, on ...

Takeda Pharmaceutical has agreed to buy Shire PLC for $62 billion, successfully ending a takeover battle for the Ireland-based drugmaker and creating a company with leading treatments for rare ...

Shire is known as one of the world's fastest growing specialty pharmaceutical companies. Today, it has value around US $5billion and is the third largest pharma company in the UK.

Shire has agreed to pay $56.5 million to settle allegations that it overstated the efficacy of several of its drugs, including the attention-deficit treatment Adderall XR, the Department of ...

Takeda Pharmaceutical Co.4502-4.65%decrease; red down pointing triangle on Tuesday reached an agreement to buy Shire PLC, capping a monthslong battle for control of the European drugmaker and ...

The planned expansion of Shire Pharmaceutical's Lexington facility is being called a "U.S. headquarters," but it will be essentially act as the drug giant's global seat of operations. That news ...

Shire notes the announcement made by Takeda. The Board of Shire (the "Board") confirms that it has received three conditional proposals from Takeda regarding a possible offer for the Company, on 29 ...

Shire notes the announcement made by Takeda and confirms it has received a fourth proposal on 20 April 2018 regarding a possible offer for the Company (the "Fourth Proposal"). The Fourth Proposal ...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR ...